Risk Factors of Metabolic Syndrome Among Patients Receiving Antipsychotics: A Retrospective Study.
Antipsychotics
Arabs
Mental health
Metabolic syndrome
Qatar
Retrospective
Journal
Community mental health journal
ISSN: 1573-2789
Titre abrégé: Community Ment Health J
Pays: United States
ID NLM: 0005735
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
06
03
2019
accepted:
23
12
2019
pubmed:
31
12
2019
medline:
29
7
2021
entrez:
30
12
2019
Statut:
ppublish
Résumé
This study aimed to assess the differential effects of first-generation (FGA) and second-generation antipsychotics (SGA) on the prevalence of risk factors for metabolic syndrome among mentally ill patients in Qatar. We also wanted to check if there is proper adherence with the guidelines for prescribing antipsychotics and the monitoring of metabolic effects in this population. We collected the available retrospective data (socio-demographic, psychiatric, anthropometric, and metabolic measures) from the records of 439 patients maintained on antipsychotics. The majority were males, married, employed, having a psychotic disorder, and receiving SGA. Patients on SGA showed more obesity, higher BP, and more elevated triglycerides compared to those on FGA. The prevalence of the abnormal metabolic measures was high in this sample, but those on SGA showed a significantly higher prevalence of abnormal body mass index and BP. Obesity and hypertension were common in patients maintained on antipsychotics, especially those on SGA. Polypharmacy was common, and many metabolic measures were not monitored properly in those maintained on antipsychotics. More prospective studies with guided monitoring of the patients' clinical status and metabolic changes are needed to serve better this population of patients.
Identifiants
pubmed: 31884574
doi: 10.1007/s10597-019-00537-y
pii: 10.1007/s10597-019-00537-y
pmc: PMC7089884
doi:
Substances chimiques
Antipsychotic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
760-770Références
Riv Psichiatr. 2016 Jan-Feb;51(1):37-42
pubmed: 27030348
Nat Rev Endocrinol. 2011 Oct 18;8(2):114-26
pubmed: 22009159
J Pharm Pract. 2012 Jun;25(3):368-73
pubmed: 22551560
Psychiatr Danub. 2012 Sep;24(3):314-22
pubmed: 23013638
BJPsych Open. 2015 Jul 24;1(1):27-33
pubmed: 27703720
Ther Adv Psychopharmacol. 2015 Feb;5(1):4-12
pubmed: 25653825
Gen Hosp Psychiatry. 2017 Mar - Apr;45:62-69
pubmed: 28274341
Hum Psychopharmacol. 2012 Sep;27(5):521-6
pubmed: 22996619
Biol Psychiatry. 2010 Feb 1;67(3):255-62
pubmed: 19897178
Expert Rev Neurother. 2013 Jul;13(7):767-83
pubmed: 23898849
J Clin Psychopharmacol. 2015 Apr;35(2):193-5
pubmed: 25679123
Diabetes Metab Syndr. 2018 Apr - Jun;12(2):195-201
pubmed: 29203060
Handb Exp Pharmacol. 2012;(212):187-212
pubmed: 23129333
Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):e13-8
pubmed: 14766739
Am J Geriatr Psychiatry. 2015 Jun;23(6):596-606
pubmed: 25154537
J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32
pubmed: 20863953
Psychiatr Danub. 2013 Sep;25(3):306-10
pubmed: 24048402
Psychiatr Danub. 2012 Sep;24 Suppl 1:S128-9
pubmed: 22945205
J Clin Psychiatry. 2005 Feb;66(2):167-73
pubmed: 15705001
PLoS One. 2016 Feb 16;11(2):e0149209
pubmed: 26882230
Eur J Clin Pharmacol. 2014 Dec;70(12):1433-41
pubmed: 25291992
BMC Psychiatry. 2018 Mar 27;18(1):81
pubmed: 29587717
J Clin Psychiatry. 2011 Dec;72(12):1592-9
pubmed: 22244021
Int J Mol Sci. 2017 Oct 18;18(10):
pubmed: 29057817
BMC Psychiatry. 2012 Dec 27;12:235
pubmed: 23270504
BMJ Open. 2015 Oct 01;5(10):e007633
pubmed: 26428329
J Correct Health Care. 2017 Apr;23(2):203-213
pubmed: 28366084
Diabetes Metab Syndr. 2014 Jan-Mar;8(1):24-9
pubmed: 24661754
Eur Neuropsychopharmacol. 2005 Aug;15(4):399-409
pubmed: 15925493
Nord J Psychiatry. 2011 Oct;65(5):345-52
pubmed: 21428861
Metab Brain Dis. 2015 Feb;30(1):107-13
pubmed: 25034455
Schizophr Res. 2010 Nov;123(2-3):244-50
pubmed: 20850274
Int J Environ Res Public Health. 2018 May 07;15(5):
pubmed: 29735938
Clin Biochem. 2007 Sep;40(13-14):1026-31
pubmed: 17601525
Psychiatry Clin Neurosci. 2018 Aug;72(8):572-579
pubmed: 29761577
Eur Psychiatry. 2012 May;27(4):267-74
pubmed: 21036549
Health Justice. 2016;4:6
pubmed: 27340612
Schizophr Bull. 2013 Mar;39(2):306-18
pubmed: 22207632
J Clin Psychopharmacol. 2018 Oct;38(5):447-453
pubmed: 30113352
Int J Ment Health Nurs. 2018 Feb;27(1):196-203
pubmed: 28093900
Pharmacol Res. 2015 Nov;101:74-85
pubmed: 26218604
Neuro Endocrinol Lett. 2012;33(5):493-8
pubmed: 23090266
Schizophr Res. 2008 Apr;101(1-3):295-303
pubmed: 18299188
Schizophr Res. 2011 Mar;126(1-3):93-102
pubmed: 21071179
World Psychiatry. 2018 Feb;17(1):49-66
pubmed: 29352556
Lancet. 2009 Aug 22;374(9690):635-45
pubmed: 19700006
Hum Psychopharmacol. 2013 Mar;28(2):188-91
pubmed: 23475497
World Psychiatry. 2015 Oct;14(3):339-47
pubmed: 26407790